High-Sensitivity Cardiac Troponin I and Clinical Outcomes of Major Acute Cardiac Events

Michelle N Steiner1, Niti B Vyas1, Juan U Rojo1

  • 1Department of Clinical Laboratory Science, University of Texas Medical Branch, Galveston, TX, United States.

Insights

Using sex-specific reference limits with high-sensitivity troponin I assays identifies patients at higher cardiovascular risk, yet these patients show improved long-term outcomes. This approach may have clinical value and highlights the obesity paradox.

Area of Science:

  • Cardiology
  • Biomarkers
  • Clinical Diagnostics

Background:

  • Emerging evidence supports sex-specific 99th percentile upper reference limits (URLs) with high-sensitivity cardiac troponin (hs-cTn) assays for acute coronary syndrome (ACS).
  • The clinical utility of reclassifying patients using these sex-specific URLs requires further investigation.

Purpose of the Study:

  • To evaluate the long-term outcomes of patients reclassified by sex-specific URLs using the Beckman Coulter Access high-sensitivity troponin I (hs-cTnI) assay.
  • To compare outcomes between reclassified patients and controls.

Main Methods:

  • A retrospective observational study included 1486 emergency department patients with hs-cTnI results.
  • Patients exceeding sex-specific URLs but below conventional URLs were identified and compared to non-reclassified controls.

Main Results:

  • Reclassification was more frequent in women (7.6%) than men (5.7%) and associated with higher rates of major adverse cardiac events (MACEs), coronary artery disease, and cerebrovascular disease.
  • Reclassified patients had a significantly longer time to first post-ED MACE.
  • Reclassification independently predicted a 52.5% lower hazard of MACE over time (P = 0.016). Class 1 obesity was associated with a 68.2% hazard reduction (P < 0.001).

Conclusions:

  • Integrating sex-specific URLs with hs-cTnI assays identifies patients with increased cardiovascular risk who have improved long-term outcomes, suggesting clinical value.
  • The findings support the obesity paradox, linking Class 1 obesity to reduced MACE risk.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
943
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
751
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
971